• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Methodologic shortcomings inherent in a post-hoc analysis.

作者信息

Staskin David R

机构信息

New York Presbyterian Hospital, Weill-Cornell Medical School, New York, NY 10021, USA.

出版信息

Curr Urol Rep. 2002 Dec;3(6):431-3. doi: 10.1007/s11934-002-0092-6.

DOI:10.1007/s11934-002-0092-6
PMID:12425862
Abstract
摘要

相似文献

1
Methodologic shortcomings inherent in a post-hoc analysis.事后分析中固有的方法学缺陷。
Curr Urol Rep. 2002 Dec;3(6):431-3. doi: 10.1007/s11934-002-0092-6.
2
POEMS (patient-oriented evidence that matters) spark discussion.POEMS（以患者为导向的重要证据）引发了讨论。
J Fam Pract. 2001 Oct;50(10):901.
3
Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.氯奥昔布宁缓释剂、酒石酸托特罗定速释剂和长效剂治疗儿童日间尿失禁的疗效
J Urol. 2003 Jan;169(1):317-9. doi: 10.1016/S0022-5347(05)64115-8.
4
Detrol LA and Diropan XL for overactive bladder.得妥长效制剂和尿多灵长效制剂用于治疗膀胱过度活动症。
Med Lett Drugs Ther. 2001 Apr 2;43(1101):28.
5
RE: Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.
J Urol. 2003 Sep;170(3):928; author reply 928. doi: 10.1097/01.ju.0000080841.60873.b1.
6
Overactive bladder: improving the efficacy of anticholinergics by dose escalation.
Curr Urol Rep. 2003 Dec;4(6):446-51. doi: 10.1007/s11934-003-0025-z.
7
Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial.
Curr Urol Rep. 2002 Oct;3(5):343-4. doi: 10.1007/s11934-002-0074-8.
8
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.氯氮卓斯汀缓释片与酒石酸托特罗定治疗膀胱过度活动症的前瞻性随机对照试验：OBJECT研究结果
Mayo Clin Proc. 2001 Apr;76(4):358-63.
9
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.奥昔布宁和托特罗定缓释制剂治疗膀胱过度活动症疗效和耐受性的前瞻性、随机、双盲研究：OPERA试验结果
Mayo Clin Proc. 2003 Jun;78(6):687-95. doi: 10.4065/78.6.687.
10
Pharmacotherapy of the overactive bladder and advances in drug delivery.膀胱过度活动症的药物治疗及药物递送进展
Clin Obstet Gynecol. 2002 Mar;45(1):205-17. doi: 10.1097/00003081-200203000-00022.

引用本文的文献

1
Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.膀胱过度活动症的药物治疗：已发表的经济学评价的系统与批判性综述
Pharmacoeconomics. 2005;23(10):995-1006. doi: 10.2165/00019053-200523100-00003.

本文引用的文献

1
Medical treatment of overactive bladder.
Mayo Clin Proc. 2001 Nov;76(11):1179-80. doi: 10.4065/76.11.1179.
2
Sponsorship, authorship, and accountability.赞助、作者身份及责任。
N Engl J Med. 2001 Sep 13;345(11):825-6; discussion 826-7. doi: 10.1056/NEJMed010093.
3
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.氯氮卓斯汀缓释片与酒石酸托特罗定治疗膀胱过度活动症的前瞻性随机对照试验：OBJECT研究结果
Mayo Clin Proc. 2001 Apr;76(4):358-63.
4
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.托特罗定每日一次：治疗膀胱过度活动症疗效更佳且耐受性良好。
Urology. 2001 Mar;57(3):414-21. doi: 10.1016/s0090-4295(00)01113-4.
5
Tolterodine--a new bladder-selective antimuscarinic agent.托特罗定——一种新型膀胱选择性抗毒蕈碱药物。
Eur J Pharmacol. 1997 May 30;327(2-3):195-207. doi: 10.1016/s0014-2999(97)89661-6.
6
Principles of clinical trial design.临床试验设计原则
Semin Oncol. 1988 Oct;15(5):423-33.